<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01437917</url>
  </required_header>
  <id_info>
    <org_study_id>LOC/11-05 - NOMAC</org_study_id>
    <secondary_id>2011-A00517-34</secondary_id>
    <secondary_id>11/19-808</secondary_id>
    <secondary_id>B110607-50</secondary_id>
    <nct_id>NCT01437917</nct_id>
  </id_info>
  <brief_title>NOMAC : New Tools for Managing the Fate of Cereal Nutrients in the Gut : Effects of Amylose Content on Glycemic Index.</brief_title>
  <acronym>NOMAC</acronym>
  <official_title>NOMAC : New Tools for Managing the Fate of Cereal Nutrients in the Gut : Effects of Amylose Content on Glycemic Index.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rennes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institut National de la Recherche Agronomique</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Rennes University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The consumption of cereals-based foods with low glycemic indexes, high micronutrients and
      fibers contents are highly recommended. The target of this work is to provide new solutions
      for cereal based foods: the knowledge and understanding on the in vivo fate will be used to
      define structural features to gain in foods.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2011</start_date>
  <completion_date type="Actual">April 2012</completion_date>
  <primary_completion_date type="Actual">April 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Glycemic index for each bread</measure>
    <time_frame>2 hours</time_frame>
    <description>To compare the glycemic index of breads made with different amylose content. (S1 to S6) A total of 6 visits. In each visit, blood samples will be taken for measurement of glycemia and insulinemia over 2 hours after ingestion of 50 of carbohydrates ingested with 400 ml of water.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>AUC for insulinemia for the 2 hours following the ingestion of each bread.</measure>
    <time_frame>2 hours</time_frame>
    <description>To compare the AUC for insulinemia for the 2 hours following the ingestion of each bread.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Bread with 20% amylose content</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bread with 20% amylose content</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bread with 10% amylose content</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bread with 10% amylose content</description>
  </arm_group>
  <arm_group>
    <arm_group_label>carbohydrates</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>50g of carbohydrates ingested with 400 ml of water</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>20% amylose bread</intervention_name>
    <description>20% amylose bread</description>
    <arm_group_label>Bread with 20% amylose content</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>10% amylose bread</intervention_name>
    <description>10% amylose bread</description>
    <arm_group_label>Bread with 10% amylose content</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Carbohydrates</intervention_name>
    <description>50g of carbohydrates ingested with 400 ml of water</description>
    <arm_group_label>carbohydrates</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy individual,

          -  Age between 19-65 years

          -  With normal food habits with at least 2 main meals per day

          -  Non smoking

          -  Having filled the consent form

        Exclusion Criteria:

          -  BMI &gt; 25 kg/m2,

          -  Diabetes or any illness susceptible to alter

          -  Coeliac disease

          -  Past history of intestinal diseases.

          -  Treatment susceptible of modifying glycemia.

          -  Allergy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fabrice BONNET, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rennes University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rennes University Hospital</name>
      <address>
        <city>Rennes</city>
        <state>Bretagne</state>
        <zip>35033</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 20, 2011</study_first_submitted>
  <study_first_submitted_qc>September 20, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 21, 2011</study_first_posted>
  <last_update_submitted>May 15, 2012</last_update_submitted>
  <last_update_submitted_qc>May 15, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 16, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>glycemic index</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

